|
FANCE expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.65219948833339E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.01509994748983E-09 |
| Normal-vs-Stage2 |
1.060760E-01 |
| Normal-vs-Stage3 |
3.52339999998286E-06 |
| Normal-vs-Stage4 |
9.67149999999695E-05 |
| Stage1-vs-Stage2 |
8.512300E-02 |
| Stage1-vs-Stage3 |
8.412000E-01 |
| Stage1-vs-Stage4 |
3.065200E-01 |
| Stage2-vs-Stage3 |
1.280380E-01 |
| Stage2-vs-Stage4 |
4.063700E-02 |
| Stage3-vs-Stage4 |
2.741000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.26450027805004E-11 |
| Normal-vs-AfricanAmerican |
1.836990E-03 |
| Normal-vs-Asian |
3.233700E-04 |
| Caucasian-vs-AfricanAmerican |
4.019000E-01 |
| Caucasian-vs-Asian |
9.969800E-01 |
| AfricanAmerican-vs-Asian |
4.652800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.955200E-04 |
| Normal-vs-Female |
4.35920188834871E-11 |
| Male-vs-Female |
1.434570E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74380000439456E-08 |
| Normal-vs-Age(41-60Yrs) |
7.60739999883242E-08 |
| Normal-vs-Age(61-80Yrs) |
1.120260E-03 |
| Normal-vs-Age(81-100Yrs) |
2.377000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.549600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.071000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.392420E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.669200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.803500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.714420E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.580200E-01 |
| Classical-VS-Follicular |
3.45639999954628E-07 |
| Classical-VS-Other |
5.584600E-01 |
| Classical-VS-Normal |
1.77813319623965E-12 |
| Tall-VS-Follicular |
4.978700E-04 |
| Tall-VS-Other |
5.519800E-01 |
| Tall-VS-Normal |
1.96809999999381E-05 |
| Follicular-VS-Other |
2.698400E-01 |
| Follicular-VS-Normal |
5.703200E-01 |
| Other-VS-Normal |
2.137000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.85992999999218E-05 |
| Normal-vs-N1 |
3.159400E-03 |
| N0-vs-N1 |
7.417400E-01 |
|
|
